Cargando…

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819272/ https://www.ncbi.nlm.nih.gov/pubmed/35140518 http://dx.doi.org/10.2147/CMAR.S360019

Ejemplares similares

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy
por: Kachris, Stefanos, et al.
Publicado: (2021)

Corrigendum to miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology
Publicado: (2022)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Publicado: (2020)

Biophysical and biological contributions of polyamine-coated carbon nanotubes and bidimensional buckypapers in the delivery of miRNAs to human cells [Corrigendum]
Publicado: (2018)

Corrigendum to: Computational annotation of miRNA transcription start sites
por: Wang, Saidi, et al.
Publicado: (2020)

Corrigendum to “Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish”
por: Nam, Hyun-Sik, et al.
Publicado: (2017)

Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
por: Jin, Wei, et al.
Publicado: (2020)

Application of Radiosensitizers in Cancer Radiotherapy [Corrigendum]
Publicado: (2021)

Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]
por: Ray, K.J., et al.
Publicado: (2016)

Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
por: Zedan, Ahmed H., et al.
Publicado: (2018)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
Publicado: (2021)

Corrigendum: miRNA-296-5p functions as a potential tumor suppressor in human osteosarcoma by targeting SND1
Publicado: (2021)

Exosomal miRNAs as Biomarkers for Prostate Cancer
por: Hessvik, Nina Pettersen, et al.
Publicado: (2013)

Circulating miRNAs as Potential Biomarkers for Celiac Disease Development
por: Tan, Ineke L., et al.
Publicado: (2021)

Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?
por: Prajzlerová, Klára, et al.
Publicado: (2022)

Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

Corrigendum to: Topologically inferring active miRNA‐mediated subpathways toward precise cancer classification by directed random walk
Publicado: (2019)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Corrigendum to: miRNA expression profile of retinal pigment epithelial cells under oxidative stress conditions
por: Donato, Luigi, et al.
Publicado: (2018)

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]
Publicado: (2020)

Corrigendum to “Quantitative Detection of miRNA-21 Expression in Tumor Cells and Tissues Based on Molecular Beacon”
por: Liu, Qingxin, et al.
Publicado: (2020)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
por: Endzeliņš, Edgars, et al.
Publicado: (2017)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Corrigendum to “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation”
por: Brocco, D., et al.
Publicado: (2020)

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
por: Arrighetti, Noemi, et al.
Publicado: (2021)

Corrigendum #2 to “Quantitative Detection of miRNA-21 Expression in Tumor Cells and Tissues Based on Molecular Beacon”
por: Liu, Qingxin, et al.
Publicado: (2021)

The Blood Biomarkers of Thyroid Cancer [Corrigendum]
Publicado: (2022)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Expression Analysis of miRNAs and Their Potential Role as Biomarkers for Prostate Cancer Detection
por: Bergez-Hernández, Fernando, et al.
Publicado: (2022)

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
por: Lajer, C B, et al.
Publicado: (2017)

A 19-miRNA Support Vector Machine classifier and a 6-miRNA risk score system designed for ovarian cancer patients
por: Dong, Jingwei, et al.
Publicado: (2019)

[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
por: Cai, Chao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4lmc9btqrehe3pplo5ledsg6sh